News | April 13, 2026
Unichem’s US arm recalls Buspirone tablets after stability test OOS result
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The event also featured discussions on emerging trends in joint replacement surgery
The collaboration brings together AIG Hospitals’ high-volume clinical expertise, advanced innovation capabilities, and growing artificial intelligence-led healthcare initiatives
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
Subscribe To Our Newsletter & Stay Updated
